Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;10(3):203-11.
doi: 10.1111/eip.12282. Epub 2015 Oct 20.

Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker

Robert K McNamara  1 , Ronald Jandacek  2 , Patrick Tso  2 , Thomas J Blom  1 , Jeffrey A Welge  1 , Jeffrey R Strawn  1 , Caleb M Adler  1 , Stephen M Strakowski  1 , Melissa P DelBello  1
Affiliations

Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker

Robert K McNamara et al. Early Interv Psychiatry. 2016 Jun.

Abstract

Aim: Mood disorders are associated with low levels of the long-chain omega-3 (LCn-3) fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). This study investigated LCn-3 fatty acid biostatus in youth with or at varying risk for developing mania to assess its utility as a prodromal risk biomarker.

Method: Erythrocyte fatty acid composition was determined in healthy adolescents (n = 28, HC), asymptomatic adolescents with a biological parent with bipolar I disorder (n = 30; 'high risk', HR), adolescents with a biological parent with bipolar I disorder and major depressive disorder, or depressive disorder not otherwise specified (n = 36; 'ultra-high risk', UHR), and first-episode adolescent bipolar manic patients (n = 35, BP).

Results: Group differences were observed for DHA (P ≤ 0.0001) and EPA (P = 0.03). Compared with HC, erythrocyte EPA + DHA ('omega-3 index') was significantly lower in BP (-24%, P ≤ 0.0001) and UHR (-19%, P = 0.0006) groups, and there was a trend in the HR group (-11%, P = 0.06). Compared with HC (61%), a greater percentage of HR (77%, P = 0.02), UHR (80%, P = 0.005) and BP (97%, P = 0.001) subjects exhibited EPA + DHA levels of ≤4.0%. Among all subjects (n = 130), EPA + DHA was inversely correlated with manic (r = -0.29, P = 0.0008) and depressive (r = -0.28, P = 0.003) symptom severity. The AA/EPA + DHA ratio was significantly greater in BP (+22%, P = 0.0002) and UHR (+16%, P = 0.001) groups.

Conclusions: Low EPA + DHA levels coincide with the initial onset of mania, and increasing risk for developing bipolar disorder is associated with graded erythrocyte EPA + DHA deficits. Low erythrocyte EPA + DHA biostatus may represent a promising prodromal risk biomarker warranting additional evaluation in future prospective studies.

Keywords: arachidonic acid (AA); eicosapentaenoic acid (EPA); mania; omega-3 index; ultra-high risk.

PubMed Disclaimer

Figures

Figure 1
Figure 1
YMRS (A) and HDRS (B) total scores for healthy comparison subjects (HC, n=28), asymptomatic adolescents with a biological parent with bipolar I disorder (‘high-risk’, HR; n=31), adolescents with a biological parent with bipolar I disorder and MDD or depressive disorder-NOS (‘ultra high-risk’, UHR; n=36), and first-episode bipolar patients (BP, n=35). Values are group mean ± S.E.M. ***P≤0.0001 vs. HC, ##P≤0.01, ###P≤0.001 vs. HR, ++P≤0.01, +++P≤0.001 vs. UHR.
Figure 2
Figure 2
Erythrocyte membrane EPA+DHA (omega-3 index)(A), arachidonic acid (AA)(B), and the AA/EPA+DHA ratio (C) in healthy comparison (HC), high-risk (HR), ultra high-risk (UHR) and first-episode bipolar (BP) groups. Fatty acids are expressed as weight percent of total fatty acids (mg fatty acid/100 mg fatty acids) or ratio. Values are group mean ± S.E.M. ***P≤0.0001 vs. HC, #P≤0.05, ##P≤0.01 vs. HR.
Figure 3
Figure 3
Percentage of subjects in the healthy comparison (HC), high-risk (HR), ultra high-risk (UHR), and first-episode bipolar (BP) groups with an omega-3 index (EPA+DHA) of ≤4.0% (A) or a AA/EPA+DHA ratio ≤4.6 (median-split)(B). *P≤0.05, **P≤0.01, ***P≤0.0001 vs. HC, #P≤0.05, ###P≤0.001 vs. HR, +++P≤0.001 vs. UHR (Chi-Square test).
See this image and copyright information in PMC

Comment in

References

    1. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA. STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) Biol Psychiatry. 2004;55:875–881. - PubMed
    1. Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009;11:391–400. - PMC - PubMed
    1. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123C:48–58. - PubMed
    1. DelBello MP, Geller B. Review of studies of child and adolescent offspring of bipolar parents. Bipolar Disord. 2001;3:325–334. - PubMed
    1. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. 2nd Edition. New York: Oxford University Press; 2007.

Publication types